Hat mitgewirkt an:
-
Development of light- and ligand-controlled release systems for biomolecules and nanoparticles
-
Overcoming physiological barriers to nanoparticle delivery - are we there yet?
-
Reversible shielding and immobilization of liposomes and viral vectors by tailored antibody‐ligand interactions
-
Reversible Shielding and Immobilization of Liposomes and Viral Vectors by Tailored Antibody‐Ligand Interactions